Higher education and cannabis policy: what UNLV’s Riana Durrett signals for the sector

What UNLV published

On 27 July 2026 the University of Nevada, Las Vegas published a feature presenting Riana Durrett’s perspective on higher education’s role in cannabis policy. The piece frames universities as institutions that can inform regulation, provide training and produce evidence relevant to public health, regulatory science and industry practice.

How universities commonly contribute to cannabis policy

The UNLV feature makes a broader point that applies across jurisdictions: higher-education institutions perform several distinct functions that intersect with cannabis and hemp industries.

• Research and evidence generation - Universities run basic and applied studies, from pharmacology to public-health surveillance and social-policy research. Those outputs feed into regulators and clinical guidance.
• Workforce education - Degree programmes, short courses and continuing professional development supply regulators, lab technicians, clinicians and compliance officers with relevant skills.
• Testing and laboratory capacity - Academic labs can develop analytical methods, compare testing protocols and validate approaches for potency and contaminant testing.
• Policy advising and convening - Institutions often host convenings, provide expert testimony and act as neutral convenors where industry, regulators and community groups need a shared technical baseline.
• Ethics, law and governance analysis - Law schools and ethics centres study licensing regimes, criminal-justice consequences and regulatory design options, which shape public debate and legislative drafting.

Why this matters for industry professionals

For cultivators, breeders and seedbanks, the university role is not abstract. Research laboratories can help validate claims about product chemistry and safety. Curriculum and training programmes can reduce skills gaps among compliance officers and lab technicians. Policy analysis from campuses often shapes the regulatory questions that agencies ask and the evidence they require.

At the same time, university engagement raises practical issues for industry partners. Agreements around intellectual property, data-sharing and publication timelines can create tension between commercial confidentiality and academic norms. Lab-methods developed in an academic setting may not map immediately to regulatory test methods or accreditations used by commercial labs.

Limits and unanswered questions

The UNLV feature is valuable as a statement of institutional intent, but it does not resolve several recurring questions that industry actors should watch for elsewhere:

• How will universities handle conflicts between open-science norms and commercial partners seeking confidentiality? Contract terms and IP clauses vary widely.
• Will academic research translate into regulatory standards, or remain exploratory? The pathway from a university study to agency guidance is not automatic.
• What funding sources will support cannabis research? Public grants, philanthropic funds and industry contracts each shape research priorities and perceived independence.
• How will universities partner with commercial testing labs on accreditation and method transfer so results are accepted by regulators and buyers?

Practical implications for different stakeholders

Regulators should expect universities to supply evidence and technical expertise, but must also set clear standards for method validation and data access if they plan to rely on academic outputs. Breeders and seedbanks can gain from collaborative genetics research, but should plan IP and confidentiality arrangements in advance. Laboratories and service providers will need to translate academic methods into accredited workflows acceptable to regulators and retailers.

What to watch next

Following the UNLV publication, industry participants should look for several concrete developments:

• New degree or certificate programmes aimed specifically at cannabis science, regulation or business.
• Research partnerships between universities and accredited commercial labs that include method transfer or round-robin testing.
• Funding announcements - public grant programmes or private consortia - that define research priorities and shape the evidence base available to policymakers.
• Guidance from regulators that references academic studies or formally accepts university-developed methods.
• Statements from universities about IP policy and data-sharing for cannabis-related research collaborations.

Editorial judgement

Higher education can provide technical capacity and a degree of independence that is useful to policymakers and industry alike. The value to the sector depends on the details of how collaborations are structured. Universities that can offer accredited method validation, clear IP terms and training aligned with regulatory needs will be more useful to commercial partners. Conversely, where expectations on publication and openness collide with commercial confidentiality, partnerships will require careful contracting.

Who should pay attention

Regulators, research directors at cultivators and processors, laboratory directors and IP managers at seedbanks should all take note. Clinical researchers and public-health teams will also want to track university outputs as they can feed into guidance on therapeutic use and safety monitoring.

Source and Further Reading

Original reporting: Cultivating Cannabis Policy: Riana Durrett Explains Higher Education’s Role - University of Nevada, Las Vegas | UNLV